Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Buprenorphine analogue inhibits morphine-induced behavioral sensitization in mice

Dec. 10, 2004

RiVax, first ricin vaccine to enter human clinical trials

Dec. 2, 2004

Tetrodin studied in phase II trial of opiate-dependent subjects

Nov. 18, 2004

Lobeline enters clinical trials for methamphetamine addiction

Oct. 29, 2004

Nociceptin opioid receptor antagonist may be useful in the management of addictive disorders

Oct. 27, 2004

New mGluR5 antagonists prepared and tested at Addex

Oct. 26, 2004

Topiramate as a novel approach to alcoholism

Oct. 19, 2004

Promising clinical results reported for NicVAX in smoking cessation

Oct. 4, 2004

Full enrollment reached in phase II trial of CYT002-NicQb

Sep. 30, 2004

BPC-157 lessens effects of alcohol intoxication and withdrawal

Sep. 29, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...